Translational research transforms currently available knowledge into useful measures for everyday clinical and public health practices. Translation research aims to assess the implementation of standards of care, understand the barriers to their implementation, and intervene across all levels of health care delivery and public health to improve the quality of care and health outcomes, including quality of life.1
BRIDGES (Bringing Research in Diabetes to Global Environments and Systems) was developed by the International Diabetes Federation to provide strategies and solutions to support translational research efforts worldwide. With a budget of USD 10 million over a period of seven years (2007-2014), BRIDGES invested in primary and secondary prevention of diabetes worldwide. The programme had five primary objectives:
Enhancing health systems
Improving access to affordable quality care and education
Strengthening preventive efforts worldwide
Reinforcing the human rights of people with diabetes
Improving quality of life
BRIDGES has financially supported and mentored 41 projects in 36 countries. For more information about the individual projects, click on the map and projects listed below.
The BRIDGES programme was supported by an educational grant from Lilly Diabetes,
BRIDGES is now closed and no longer accepting applications for support.
1. Narayan et al. "Diabetes Translation Research: Where are We and Where Do We Want to Be?" Ann Intern Med, 2004; 140:958-963